Cohance Lifesciences Limited (BOM:543064)

Cohance Lifesciences Statistics

Total Valuation

BOM:543064 has a market cap or net worth of INR 374.67 billion. The enterprise value is 376.09 billion.

Market Cap	374.67B
Enterprise Value	376.09B

Important Dates

The next estimated earnings date is Friday, August 8, 2025.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	382.57M
Shares Outstanding	n/a
Shares Change (YoY)	+0.70%
Shares Change (QoQ)	+2.97%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	229.46M

Valuation Ratios

The trailing PE ratio is 139.87 and the forward PE ratio is 56.79.

PE Ratio	139.87
Forward PE	56.79
PS Ratio	31.29
PB Ratio	20.36
P/TBV Ratio	38.33
P/FCF Ratio	282.87
P/OCF Ratio	130.02
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 100.24, with an EV/FCF ratio of 283.95.

EV / Earnings	140.40
EV / Sales	31.40
EV / EBITDA	100.24
EV / EBIT	126.33
EV / FCF	283.95

Financial Position

The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.15.

Current Ratio	2.43
Quick Ratio	1.57
Debt / Equity	0.15
Debt / EBITDA	0.74
Debt / FCF	2.11
Interest Coverage	24.11

Financial Efficiency

Return on equity (ROE) is 13.61% and return on invested capital (ROIC) is 8.79%.

Return on Equity (ROE)	13.61%
Return on Assets (ROA)	7.04%
Return on Invested Capital (ROIC)	8.79%
Return on Capital Employed (ROCE)	11.16%
Revenue Per Employee	10.04M
Profits Per Employee	2.25M
Employee Count	1,193
Asset Turnover	0.45
Inventory Turnover	1.53

Taxes

In the past 12 months, BOM:543064 has paid 791.50 million in taxes.

Income Tax	791.50M
Effective Tax Rate	23.01%

Stock Price Statistics

The stock price has increased by +0.02% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+0.02%
50-Day Moving Average	1,019.86
200-Day Moving Average	1,129.73
Relative Strength Index (RSI)	39.91
Average Volume (20 Days)	5,941

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:543064 had revenue of INR 11.98 billion and earned 2.68 billion in profits. Earnings per share was 10.45.

Revenue	11.98B
Gross Profit	8.92B
Operating Income	2.98B
Pretax Income	3.44B
Net Income	2.68B
EBITDA	3.75B
EBIT	2.98B
Earnings Per Share (EPS)	10.45

Balance Sheet

The company has 2.80 billion in cash and 2.79 billion in debt, giving a net cash position of 13.40 million.

Cash & Cash Equivalents	2.80B
Total Debt	2.79B
Net Cash	13.40M
Net Cash Per Share	n/a
Equity (Book Value)	18.41B
Book Value Per Share	66.64
Working Capital	5.23B

Cash Flow

In the last 12 months, operating cash flow was 2.88 billion and capital expenditures -1.56 billion, giving a free cash flow of 1.32 billion.

Operating Cash Flow	2.88B
Capital Expenditures	-1.56B
Free Cash Flow	1.32B
FCF Per Share	n/a

Margins

Gross margin is 74.51%, with operating and profit margins of 24.86% and 22.37%.

Gross Margin	74.51%
Operating Margin	24.86%
Pretax Margin	28.72%
Profit Margin	22.37%
EBITDA Margin	31.33%
EBIT Margin	24.86%
FCF Margin	11.06%

Dividends & Yields

BOM:543064 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.70%
Shareholder Yield	n/a
Earnings Yield	0.71%
FCF Yield	0.35%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.

Last Split Date	Sep 25, 2020
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	5